 PAVmed Inc. Nasdaq: PAVM, PAVMZ the Company or PAVmed, a highly differentiated, multiproduct medical device company, today announced it has received 6.3 million in new gross proceeds from the prepayment of promissory notes issued in conjunction with a previously disclosed November 2019 private placement the Financing. On November 4, 2019, the Company consummated a 14 million private placement of senior secured convertible notes to two institutional investors the Investors. 